Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer
Breast cancer is the second leading cause of death for women worldwide. The
heterogeneity of this disease presents a big challenge in its therapeutic management …
heterogeneity of this disease presents a big challenge in its therapeutic management …
Towards targeting the breast cancer immune microenvironment
The tumour immune microenvironment is shaped by the crosstalk between cancer cells,
immune cells, fibroblasts, endothelial cells and other stromal components. Although the …
immune cells, fibroblasts, endothelial cells and other stromal components. Although the …
Global stage distribution of breast cancer at diagnosis: a systematic review and meta-analysis
JDB Fuentes, E Morgan, A de Luna Aguilar… - JAMA …, 2024 - jamanetwork.com
Importance Stage at diagnosis is a key prognostic factor for cancer survival. Objective To
assess the global distribution of breast cancer stage by country, age group, calendar period …
assess the global distribution of breast cancer stage by country, age group, calendar period …
Circular RNAs in breast cancer diagnosis, treatment and prognosis
X Huang, C Song, J Zhang, L Zhu… - Oncology research, 2023 - pmc.ncbi.nlm.nih.gov
Breast cancer has surpassed lung cancer to become the most common malignancy
worldwide. The incidence rate and mortality rate of breast cancer continue to rise, which …
worldwide. The incidence rate and mortality rate of breast cancer continue to rise, which …
Emerging application of magnetic nanoparticles for breast cancer therapy
TT Dongsar, TS Dongsar, MAS Abourehab… - European Polymer …, 2023 - Elsevier
Breast carcinoma is among the most commonly diagnosed cancer in females, responsible
for 15% of all cancer affiliated mortalities and 23% of all cancer incidence. Based on the …
for 15% of all cancer affiliated mortalities and 23% of all cancer incidence. Based on the …
[HTML][HTML] The role of NF-κB in breast cancer initiation, growth, metastasis, and resistance to chemotherapy
Breast cancer (BC) is the second most fatal disease and is the prime cause of cancer allied
female deaths. BC is caused by aberrant tumor suppressor genes and oncogenes regulated …
female deaths. BC is caused by aberrant tumor suppressor genes and oncogenes regulated …
Discovery of plant-derived anti-tumor natural products: Potential leads for anti-tumor drug discovery
Z Hui, H Wen, J Zhu, H Deng, X Jiang, XY Ye… - Bioorganic …, 2024 - Elsevier
Natural products represent a paramount source of novel drugs. Numerous plant-derived
natural products have demonstrated potent anti-tumor properties, thereby garnering …
natural products have demonstrated potent anti-tumor properties, thereby garnering …
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
F Bray, M Laversanne, H Sung, J Ferlay… - CA: a cancer journal …, 2024 - Wiley Online Library
This article presents global cancer statistics by world region for the year 2022 based on
updated estimates from the International Agency for Research on Cancer (IARC). There …
updated estimates from the International Agency for Research on Cancer (IARC). There …
A comprehensive investigation of multimodal deep learning fusion strategies for breast cancer classification
In breast cancer research, diverse data types and formats, such as radiological images,
clinical records, histological data, and expression analysis, are employed. Given the intricate …
clinical records, histological data, and expression analysis, are employed. Given the intricate …
The gut microbiota in breast cancer development and treatment: The good, the bad, and the useful!
Regardless of the global progress in early diagnosis and novel therapeutic regimens, breast
carcinoma poses a devastating threat, and the advances are somewhat marred by high …
carcinoma poses a devastating threat, and the advances are somewhat marred by high …